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INTRODUCTION 
Rheumatoid arthritis (RA) is a chronic multisystem disease of 
autoimmune aetiology. The characteristic feature is the persistent 
inflammatory synovitis usually involving peripheral joints in a symmetric 
distribution. Though it is considered a disease predominantly involving the 
joints it can cause a variety of extra articular manifestations. It can affect 
skin, eye, cardiovascular, respiratory and nervous systems and may produce 
haematological complications including  an increase in the risk of Hodgkin’s 
disease, non Hodgkin’s lymphomas, leukemias independent of the  
immunosuppressive drugs. One of the important extra articular 
manifestations is the involvement of nervous system. Neurological 
manifestations may be due to the involvement of central nervous system, 
peripheral nervous system or autonomic nervous system. They may be either 
due to the vascular involvement, direct compression or immune mediated 
mechanism. Autonomic neuropathy in Rheumatoid arthritis is rare. But 
recent studies have shown variable results and it varied from 0-70% 
symptomatic or asymptomatic. It can effect parasympathetic only or 
sympathetic only or both. Most common is the parasympathetic 
involvement. An important adverse effect of autonomic neuropathy is 
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cardiac autonomic neuropathy, as it can lead to increase in morbidity and 
mortality. Cardiac autonomic neuropathy can lead to sudden cardiac death, 
various arrhythmias, adverse effect to drugs, increase  incidence of frequent 
falls especially in elderly further aggravating the morbidity. 
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REVIEW OF LITERATURE 
Epidemiology 
RA is widely distributed all over the world and affects all races. The 
prevalence in the adult population is assessed at approximately 0.5 to 1.The 
prevalence and incidence is 3 times higher in the females than the males2. 
The incidence of RA rises dramatically during adulthood. The average age at 
onset has shifted upward over the past five decades. There is a decline in the 
age specific incidence and is greatest in females 1. 
Aetiopathogenesis  
The genetic predisposition and the environmental factors(importantly 
infections) play a major role in the causation of RA. The HLA class II 
molecule particularly HLA DR4 is associated with 70% of RA patients. The 
susceptibility to RA is associated with the third  hypervariable region of the 
DR β chains from amino acids 70 through 74 3. Deficient  galactosylation of 
the immunoglobulin G might also be a risk factor for the development of 
RA. Association with genetic polymorphisms have been demonstrated with 
tumour necrosis factor–alpha, chemokines  and other cytokines. A single 
nucleotide polymorphism for the T-cell co-stimulatory molecule CTLA 4 is 
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also associated with susceptibility. Infectious agents play an aetiologic role 
in the causation of RA. The bacterial organisms are pathogenic through 
molecular mimicry and viruses cause direct synovial infection or induce 
polyclonal activation as in Ebstein-Barr viral infection.  
Rheumatoid factor was the first evidence of autoimmunity in RA. 
Rheumatoid factor (RF) is an autoantibody against the antigenic determinant 
region in the Fc portion of the IgG molecule. The IgG becomes 
immunogenic through various mechanisms. First, new determinants on IgG 
might be exposed after polymerization of molecules or formation of IgG 
complexes with specific antigens. Second structural anomalies in the IgG of 
the RA patients may render it immunogenic. Finally changes in the relative 
extent of the galactosylation of the IgG may give rise to auto antigenic 
reactivity4. Production of high affinity RF leads to intra articular 
complement fixation and synovitis. High titer IgG RF is associated with 
vasculitis, IgA RF is associated with erosions and vasculitis. Apart from that 
autoantibodies directed against the components of the articular cartilage like 
type II collagen, gp39, cartilage link protein, proteoglycans and aggrecans 
and nonarticular antigens like citrullinated peptides, glucose 6-
phosphoisomerase, HLA–DR, heatshock proteins, hnRNPA2 also play a 
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vital role in the pathogenesis of RA. Patients with active rheumatoid disease 
may develop encephalopathy, myelopathy, peripheral  neuropathy, 
autonomic neuropathy and myopathy through a variety of tissue 
mechanisms. Brain involvement is usually characterized by the formation of 
rheumatoid nodules or by the development of vasculitis or its complications, 
and there is evidence to suggest that the trapping of immune complexes 
within the choroid plexus may be important in pathogenesis.  
Structural damage to the spinal cord and lower brain stem, on the 
other hand, most commonly results from narrowing of the bony canal, 
leading either to direct compression of neural tissue or to compromise of its 
vascular supply or due to atlanto axial subluxation following the loss of 
support from the transverse, alar and apical ligaments due the inflammation 
at the synovial bursa which is present in between the transverse ligament and 
the odontoid process. The appearance of peripheral neuropathy generally 
signifies the presence either of inflammatory epineurial arterial disease or 
entrapment by neighbouring anatomical structures. Skeletal muscle 
dysfunction may be due to vasculitis, myositis, or denervation atrophy. Both 
systemic and local anatomical factors, therefore are of importance in 
determining the manner in which different parts of the nervous system may 
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be affected in rheumatoid disease. Serum levels of soluble VCAM-1, soluble 
E-selectin, and Anti Endothelial Cell antibody are higher in patients with RA 
neuropathy than in patients with RA uncomplicated by neurological disease. 
These data suggest that development of peripheral neuropathy in RA is 
associated with increased endothelial cell activation5 
Autonomic neropathy in rheumatoid arthritis may be either due to the 
vascular involvement, direct compression or immune mediated mechanism. 
s.maule,r.quadri,d.mirante et al  has found that an association between the 
complement fixing autoantibodies directed against the sympathetic ganglia 
and vagus nerve and asymptomatic autonomic dysfunction. This auto 
antibodies occurred  independenly of the presence of other conventional 
autoantibodies,thus indicating that their target antigens are tissue specific. 
The nature of these antigen remains to be determined.6 
Pathology 
The primary site of immune activation in RA is the synovium of the 
joint. Infiltration of synovium with mononuclear cells, especially T cells and 
macrophages, and synovial intimal lining hyperplasia are the hallmarks of 
the disease. The increase in the synovial intimal lining cells is substantial. 
The two types of synoviocytes, type A and B are  increased in RA with the 
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predominance of type A macrophage like cells which express the markers 
CD 68,Fc receptors,CD14 and abundant HLA –DR molecule. In chronic RA 
the synovium contains a collection of T lymphocytes that can lead to an 
organizational structure resembling a lymphnode. These collections consist 
of small CD4+ memory cells. T cells constitute about 50 % or more of cells 
in most RA synovia, and most are CD4+, only 5% or fewer of cells are B 
lymphocytes or plasma cells. Oligoclonal expansion of CD4+ CD28- T cells 
are poor B cell stimulators and occur more frequently in patients with extra 
articular manifestation. Synovial lymphocytes also bear adhesion molecules 
of very late antigen and lymphocyte function associated antigen super family 
of integrins, which may enable the inflammatory process to persist within 
the synovium. The cytokine milieu of the synovium induces the expression 
of ICAM-1, VCAM-1 and connecting segment -1 fibronectin on vascular 
endothelium. Chemokines and the chemokine receptor especially CCR5 play 
a vital role in the accumulation of T cells independent of a particular 
antigen. Synovial B cells and plasma cell hyperactivity take part in the 
perpetuation and initiation phase of RA. Dendritic cells constitute around 
5% of synovial cells which has resistance to the effects of IL-10.Other cells 
present in the synovium are polymorphonuclear cells, mast cells. Synovial 
tissue express Th1 cytokine bias which comprises IFN-γ, IL-2 and IL-
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17.Macrophages are the major source of cytokine secretion in the synovium. 
Activation of macrophages and fibroblasts occur also through cell to cell 
contact with T-lymphocytes. The pro inflammatory cytokines IL-1,IL-
6,TNF-alpha,IL-15,colony stimulating factors, chemokines, platelet derived 
growth factor and fibroblast growth factor all play an important role in the 
establishment of the synovial pathology. Underproduction of suppressive 
cytokines like IL-1Ra ,IL-10,TGF-β and soluble cytokine receptors and 
binding proteins may also contribute for the synovial inflammation. The 
most important mechanism of the bone and cartilage destruction is the 
pannus formation which is a cellular layer. Aggressive  degradation of the 
extracellular matrix occurs at the pannus cartilage junction. The enzymes 
induced by the factors IL-1, TNF-alpha, phagocytosis of debris by synovial 
cells and mechanic trauma cause the joint destruction. The MMP s and 
aggrecanases  produced by the chondrocytes through  
IL-1 mediated mechanism destroy the proteoglycans and weakens the 
cartilage thereby predisposing for a cartilage destruction. Tissue inhibitor of 
metalloproteases which is a family of proteins block the activity of 
metalloproteases by directly binding to them. Degradation of the bone 
occurs through binding of receptor activator of nuclear factor κ B ligand 
which is produced by the activated T cells and fibroblast like synoviocytes  
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with the receptor ,RANK expressed in the osteclasts which in turn will 
activate the osteoclasts. Osteoprotegerin ,a decoy receptor binds with RANK 
and competes with RANK-L.Polymorphonuclear neutrophil  activation leads 
to mobilization of membrane phospholipids and release of arachidonic acid 
metabolites. Proinflammatory product like leukotriene B4 plays a 
considerable role in in the induction of inflammation. 
Clinical features 
The clinical manifestations include articular and extra articular 
features. The articular manifestation may have an insidious onset in 55-65 % 
of patients, acute onset in 8-15% of patients and subacute in 15-20% of 
patients. The unusual pattern of onset may be adult onset Still’s disease, 
palindromic onset, polymyalgia rheumatica type and arthritis robustus type. 
The joints most commonly involved first are metacarpophalangeal joints, 
proximal interphalangeal joints, metatarsophalangeal joints and wrists. The 
large joints become symptomatic after the small joints .The extra articular 
manifestation includes subcutaneous nodules, episcleritis, scleritis, myositis, 
vasculitis, pulmonary manifestations in the form of pleurisy, interstitial 
fibrosis, nodular lung disease, bronchiolitis, pulmonary hypertension and 
small airways disease. Cardiac complications include pericarditis, 
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myocarditis, endocardial inflammation, conduction defects, coronary 
arteritis, granulomatous arteritis or valvular disease. 
Central nervous system (CNS) 
                 a)   Meningeal nodules, pachymeningitis and CNS vasculitis 
                b)    Cervical spine in Rheumatoid arthritis:  
• Atlanto Axial Dislocation,  
• Subaxial subluxation   
• Atlanto Axial Impaction 
Peripheral nerve lesions 
        Chronic or subacute compressive (entrapment) neuropathies 
a) Median nerve: Carpal tunnel syndrome is the commonest 
chronic nerve  entrapment   neuropathy.  
b) Ulnar nerve: Ulnar neuropathy is the second most frequent  
entrapment neuropathy, the majority occurring at the elbow in 
the cubital tunnel.  
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Cervico thoracic nerve roots  
                Radicular symptoms may be due to rheumatoid involvement of the  
                cervical spine (often silent) 
Common peroneal nerves   
 The common peroneal nerve is vulnerable at the level of the fibular 
head  as the nerve enters the peroneus muscle.  
Posterior tibial nerve.  
 The tarsal tunnel syndrome is not common.  
Mononeuritis multiplex 
 Mononeuritis multiplex is a painful asymmetric asynchronous sensory            
and motor peripheral neuropathy involving isolated damage to at least 2          
separate nerve areas.  
Autonomic dysfunction 
A wide range of symptoms may indicate abnormal function of the 
autonomic nervous system.The characteristic autonomic symptoms are  
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blurred vision due to defective pupillary accommodation, optic nerve or 
brain ischemia due to orthostatic hypotension, dry eyes  or mouth due to 
impaired  parasympathetic innervation to lacrimal or salivary glands, 
orthostatic light headedness with dull shoulder aching due to muscle 
ischemia as a result of hypotension; early satiety or alternating diarrhea and 
constipation due to gastrointestinal dysmotility; and urinary retention or 
sexual dysfunction due to sympathetic and parasympathetic denervation. 
Small fiber dysfunction which can cause burning or lancinating pain of the 
hands and feet, may also cause hypohidrosis,  anhidrosis or compensatory 
hyperhidrosis. 
Diagnosis 
The diagnosis of RA is by using the 1987 revised American college of 
rheumatism classification criteria7 that are based on the effective clinical 
history and examination, laboratory tests and diagnoses that exclude it. 
 1987 ACR Criteria for the Classification of Acute Arthritis of 
Rheumatoid Arthritis 25   
For classification purposes, a patient is said to have RA if he or she 
has satisfied  
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at least 4 of the following 7 criteria. Criteria 1 through 4 must have been  
present for at least 6 weeks. Patients with 2 clinical diagnoses are not  
excluded.  
1. Morning stiffness: Morning stiffness in and around the joints, lasting 
atleast 1 hour before maximal improvement. 
2. Arthritis of 3 or more joint areas: Atleast 3 joint areas simultaneously  
          have had soft tissue swelling or fluid (not bony overgrowth alone)  
          observed by a physician; the 14 possible joint areas are right or left  
          proximal interphalangeal (PIP) joints, metacarpophalangeal (MCP)  
joints, wrist, elbow, knee, ankle, and metatarsophalangeal (MPT)  
joints. 
3. Arthritis of hand joints: At least one area swollen (as defined above) 
in a wrist,  MCP or PIP joint. 
4. Symmetric arthritis:  Simultaneous involvement of the same joint 
areas (see 2 above) on both sides of the body (bilateral involvement  
          of PIPs, MCPs, or MTPs is acceptable without absolute symmetry). 
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5. Rheumatoid nodules: Subcutaneous nodules, over bony prominences, 
or extensor surfaces, or in juxta-articular  regions, observed by a 
physician. 
6. Serum rheumatoid factor: Demonstration of abnormal amounts of 
serum rheumatoid factor by any method for which the result has been 
positive in<5% of normal control subjects. 
7. Radiographic changes : Radiographic changes typical of RA  
on posteroanterior hand and wrist radiographs, which must include  
erosions or unequivocal bony decalcification localized to or most 
marked adjacent to the involved joints(osteoarthritis changes alone do 
not qualify) 
Other organ system involvement includes, 
Cardiac   : Carditis, pericarditis 
Pulmonary   :  Pleuritis, Intrapulmonary nodules,  
Interstitial   fibrosis                                                                 
Hepatic   :  Hepatitis 
Ocular  : Scleritis, Episcleritis, Dryness of the eyes 
Vascular   :  Vasculitis 
Skin    : Subcutaneous nodules, ulcers. 
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The diagnosis of RA should be confirmed or ruled out within 2 months after 
the onset of synovitis. 
Rheumatoid factor: 
Rheumatoid factor is the auto antibody reactive with the Fc portion of 
the IgG. It is found in two third of rheumatoid arthritis. Rheumatoid factor is 
not specific for rheumatoid arthritis.5% of healthy individual has 
Rheumatoid factor positivity. Rhematoid factor is not  useful as a screening 
test but can be of prognostic significance2.  
Anti cyclic citrullinated antibody (antiCCP) test: 
Anti cyclic citrullinated antibody (anti CCP) test is the latest addition 
to the list of laboratory investigations. This test is very useful in individual 
with early rheumatoid arthritis, in whom assessment of anti CCP antibody 
may be useful to confirm the diagnosis2.Anti CCP is most common in 
persons with aggressive disease  with a tendency to develop bony 
erosion2.Anti CCP antibody is present in 1.5% of normal individuals2 . It 
may be positive in 60% of seronegative RA if second generation ELISA kit 
is used.  
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Haematological parameters in Rheumatoid arthritis: 
Blood count include normocytic normochromic anaemia, normal WBC 
counts.Thombocytosis, Eosinophilia indicates severe systemic disease.2  
Imaging  studies in Rheumatoid arthritis 
Diagnosis of neurological manifestations depend on the type of 
involvement assessed with the history and clinical examination. Imaging 
plays an important role in diagnosing the cervical spine and the cerebral 
lesions. Dynamic x-rays of the cervical spine like lateral view in flexion, 
extension, neutral may be useful, in diagnosing the atlantoaxial subluxation. 
CT and MR imaging have a vital role in delineating the involvement of the 
cervical spine. An atlanto dental distance greater than 3.5 cm is considered 
abnormal in an adult. Atlanto axial impaction or superior migration of 
odontoid is diagnosed by using the Mc Gregor’s line 8 or Ranawat’s index9 . 
McGregor’s line is drawn from the posterior edge of the hard palate to the 
most caudal part of the occipital curve of the skull. The tip of the odontoid 
should be not more than 4.5 mm above the Mc Gregor’s line.Another line 
named Fischgold and Metzger’s line10 is drawn between the two digastric 
grooves which passes 10.7mm above the tip of the odontoid process 
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normally. Diagnosis of peripheral nerve lesions requires neurophysiological 
studies . 
Treatment 
Treatment of rheumatoid arthritis comprises of non pharmacological 
and pharmacological therapies. It should have comprehensive regime 
directed towards treating the basic disease and the complications. Non drug 
therapy includes patient education, counselling and rehabilitative measures 
that focus on pain control, patient adherence, rest, joint protection principles 
and exercise therapy. Drug therapy includes analgesics, nonsteroidal anti-
inflammatory drugs, corticosteroids either intra articular or systemic. 
Systemic steroids which are used as, low dose daily therapy, high dose short 
course therapy for drug induced thrombocytopenia, mononeuritis multiplex 
and interstitial lung disease, coronary arteritis. It can be used as a principal 
therapy during pregnancy when needed. Disease modifying antirheumatic 
drugs are used according to the algorithmic approach put forward by the 
American College of Rheumatology. The American College of 
Rheumatology established recommendations for the use of non biologic and 
biologic DMARDS in 2008. These guidelines are broken down by disease 
severity and by duration of disease presence at less than 6 months, 6 months 
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to 24 months, or greater than 24 months. The use of non biologic DMARDS 
is recommended early in the management (<6 months) of patients even with 
low disease activity and no features of poor prognosis. The use of 
combination DMARD therapy is phased in early and the further 
consideration of biologic DMARDS is recommended early if there are signs 
of high disease activity or features of poor prognosis. Nonbiologic  DMRDs  
include  methotrexate , glucocorticoids , leflunomide ,  sulfasalazine,     
cyclophosphamide,      hydroxychloroquine,    gold injections,  d-
penicillamine,   minocycline , azathioprine & cyclosporine. 
 Biologic DMARDs include etanercept , adalimumab , abatacept, efalizumab, 
infliximab , rituximab , and certolizumab.    
  The combination therapy is supported by the evidence shown in the 
two trials, COBRA 11 and FIN- RACO 12. The drugs used in the combination 
triple drug therapy are methotrexate, hydroxychloroquine and 
sulphasalazine. Other drugs like leflunomide, cyclosporine, azathioprine, D-
penicillamine and gold salts are used either alone or in combination when 
the conventional DMARD combination therapy fails. The TNF-alpha 
inhibitors, Etanercept which is a fusion protein of the soluble portion of the 
human TNF p75 chain of the receptor and the Fc portion of the human 
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IgG1.This drug is used in patients who fail to respond to first line drugs. 
INFLIXIMAB a chimeric monoclonal antibody has also been shown to 
reduce the clinical signs and symptoms along with slowing the radiological 
progression. ADALIMUMAB is a fully humanized monoclonal antibody 
against TNF. Other drugs like ABATACEPT, (a fusion protein of CTLA4 
with IgG), RITUXIMAB (an anti CD 20) B cell depleting agent have shown 
to have favorable results on the clinical as well as radiological progression 
of the disease. ANKINRA(recombinant IL-1 Receptor antagonist)2 it 
improves the signs and symptoms of Rheumatoid arthritis. Statins were 
found to have beneficial effects in RA. Drugs which are under trial include 
p38 MAP kinase inhibitor, anit B cell stimulator (BLyS) and other anti 
cytokine therapies. 
AUTONOMIC NEUROPATHY 
Autonomic neuropathies are a collection of syndromes and diseases 
affecting the autonomic neurons, either parasympathetic or sympathetic or 
both . Most often, they occur in conjunction with a somatic neuropathy, but 
they can also occur  in  isolation. 
The autonomic nervous system modulates numerous body functions; 
therefore, autonomic dysfunction may manifest with numerous clinical 
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phenotypes and various laboratory and neurophysiologic abnormalities.  A 
patient may present with symptoms related to a single portion of the 
autonomic system or both. The degree and type of autonomic system 
involvement varies extensively. In some patients, the degree of autonomic 
dysfunction may be subclinical or clinically irrelevant; in others, symptoms 
may be disabling.  
   CLASSIFICATION 43 
         a)   INHERRITED. 
               b)    ACQUIRED,  
• PRIMARY. 
• SECONDARY. 
INHERITED 
             Familial amyloid polyneuropathy. 
 
             Hereditary sensory autonomic neuropathy, 
      Type 1. 
      Type 2 (Morvan disease). 
      Type 3 (Riley-Day syndrome or familial 
dysautonomia). 
      Type 4. 
      Type 5. 
             Fabry disease. 
 
             Acute intermittent porphyria & variegate porphyria. 
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ACQUIRED 
Primary acquired 
 Pandysautonomia.  
 Idiopathic distal small-fiber neuropathy.  
  Holmes-Adie syndrome and Ross syndrome:  
  Chronic idiopathic anhidrosis. 
  Amyloid neuropathy.  
  Postural orthostatic tachycardia syndrome. 
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SECONDARY ACQUIRED 
            Metabolic derangements, 
                             Diabetes mellitus. 
                                        Uremic neuropathy.  
                             Hepatic disease–related neuropathy. 
           Vitamin deficiency and nutrition-related neuropathy:eg vit b12 
deficiency 
           Toxic and drug-induced autonomic neuropathy. 
           Alcohol. 
           Infectious diseases, 
Lyme disease. 
HIV infection.  
Chagas disease. 
Botulism. 
Diphtheria. 
Leprosy. 
Autoimmune conditions, 
Rheumatoid arthritis.  
systemic lupus erythematosus. 
Celiac disease.  
Sjögren syndrome.  
Guillain-Barré syndrome. 
Lambert-Eaton myasthenic syndrome.  
Paraneoplastic autonomic neuropathy.  
Inflammatory bowel disease. 
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                           Symptoms due to autonomic dysfunction43 
                  OCULAR                    RENAL 
• Blurring then graying of 
vision. 
• Blacking out. 
• Tunnel vision. 
• Sensitivity to light. 
• Difficulty with focusing. 
• Reduced lacrimation. 
• Loss of pupillary size over 
time (which is often correlated 
with loss of visual symptoms). 
 
• Nocturia.  
• Bladder urgency.  
• Bladder frequency.  
• Enuresis. 
• Incomplete bladder voiding. 
• Urinary retention. 
• Urinary incontinence. 
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                       GASTROINTESTINAL                      SEXUAL 
• Constipation.  
• Episodic diarrhea.  
• Early satiety.  
• Increased gastric motility. 
• Dysphagia.  
• Bowel atony.  
• Bowel incontinence.  
• Gastroparesis in diabetes mellitus 
(which may cause food stasis and 
subsequentvomiting)41  
•  Hyposalivation. 
• Altered sense of taste.42  
• Impotence.  
• Loss of ejaculation, and retrograde 
ejaculation in men.  
• Inability to achieve orgasm or 
nonspecific sexual dysfunction in 
both sexes. 
Sweating & Temperature regulation 
• Anhydrosis or hypohidrosis 
compensatory hyperhidrosis, & 
gustatory sweating.41 
• Hypothermia (from loss of 
shivering and inability to 
vasoconstrict to prevent heat loss) 
and  hyperpyrexia. 
 
CARDIOVASCULAR 
• Orthostatic onset of palpitations. 
• Nausea.  
• Tremulousness.  
• Presyncope with light-headedness. 
• Visual blurring, tinnitus.  
• Headache.  
• Chest pain, and shortness of 
breath. 
 
• (Elderly patients may complain of 
coat hanger or lower extremity 
discomfort. These symptoms may 
be worse after a large meal or in 
severe illness. 
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RESPIRATORY  SYSTEM 
• Impaired control of  bronchomotor tone leading to a depressed 
bronchoconstrictory response to cholinergic stimuli (caused by diabetes mellitus).
• Impaired ventilatory and heart rate response to hypoxia but not to hypercapnia, in 
patients with diabetes. 
                                                  EXTREMITIES  
• Burning feet most commonly observed in small-fiber sensory neuropathy.  
• Pruritus.  
• Dysesthesia.  
• Allodynia. 
• Hyperalgesia. 
•  Nocturnal exacerbation of symptoms.  
• Dry skin, and loss of distal leg hair.  
• Brittle nails, pallor, and cold feet. 
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CARDIAC AUTONOMIC NEUROPATHY(CAN) 
CAN is manifested by abnormal heart rate, blood pressure, and redistribution 
of  blood  flow .  The cardio vascular  anomalies  of  autonomic  neuropathy  
involve both the sympathetic and parasympathetic nervous systems15.  The 
pathogenesis of the ANS dysfunction in  patients with RA is not clearly 
understood. Vasculitis of the vasa nervorum and secondary amyloidosis has 
been proposed.25 The pathogenesis may have an immune component.  The 
presence of circulating autoantibodies against nerve growth factor, (the 
trophic factor for the development and survival of sympathetic and sensory 
neurons), cervical ganglia and the vagus nerve has been recently 
demonstrated in RA  patients who had cardiovascular ANS dysfunction.6,16 
The significance of these auto-antibodies in the pathogenesis of ANS 
dysfunction remains to be determined. The auto antibodies occurred 
independendly of the presence of other conventional antibodies, thus 
indicating that their target antigens are tissue specific. The nature of these 
auto antigens remained to be determined. The supportive evidence of an 
immune component in the pathogenesis of the autonomic dysfunction in 
rheumatoid arthritis is the pathological finding of  a perivascular 
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lymphocytic infiltrate in sympathetic ganglia section of two patient with 
rheumatoid arthritis..6 
              Three major syndromes (cardiac denervation, exercise intolerance, and 
orthostatic hypotension) are associated with dysfunction of the 
cardiovascular autonomic nervous system 18,17. Patients with CAN have 
higher resting heart rates and lower maximal heart rates during exercise than  
patients without autonomic neuropathy 19 The sole manifestation of 
asymptomatic reduced heart-rate variability does not appear to be associated 
with premature mortality.20 Symptomatic autonomic neuropathy however 
has been shown to have a poorer prognosis, revealing a 10-year mortality 
rate of approximately 27%.20 Those with symptomatic autonomic 
neuropathy may be at a higher risk of mortality compared to patients with 
asymptomatic autonomic neuropathy, because they may be part of a 
subgroup with other complications and thus more advanced disease.21 
Abnormal autonomic function is known to predispose to arrhythmogenesis 
in clinical and experimental conditions. The loss of HRV and sympathovagal 
imbalance (either increased sympathetic or reduced vagal activity) has been 
shown to be a strong and independent predictor of postinfarction mortality 
and is of prognostic value in patients with heart failure and diabetic 
neuropathy . Conversely, vagal predominance could exert protective and 
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antifibrillatory effects 22. The relative predominance in sympathetic tone 
plays a key role in the development of ventricular tachyarrhythmia. Indeed, 
in a recent long-term follow-up study on the cause of death in patients with 
RA, more sudden deaths were found in RA patients than in controls. Riise et 
al. reported that sudden deaths accounted for 11.3% of total mortality in 
patients with RA 17. 
Unexplained sudden death not associated with myocardial infarction, 
in which the heart becomes unresponsive to nerve impulses (cardiac 
denervation syndrome), has been reported in  patients with CAN 23,24. Other 
Complication of CAN includes Silent Cardiac Ischemia, Arrhythmias, 
Sudden Cardiac Death, LV Hypertrophy, Altered Coronary Vasomotor 
Dynamics, Platelet Stickiness. 
Three of the most widely used tests for the determination of CAN 
include RR-variation during deep breathing, the Valsalva manoeuvre, and 
blood pressure response to standing.25 According to the American Academy 
of Neurology, these are established tests, meaning that they are "accepted as 
appropriate by the practicing medical community for the given indication in 
the specified patient population” 26. Resting heart rate is primarily controlled 
by the parasympathetic system, whereas maximal heart rate and blood 
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pressure responses to standing27 sustained hand grip, and other types of 
exercise are mainly functions of sympathetic activity (which controls blood 
vessel tone).Though test using cardiovascular reflex are most often done on 
diabetics, they are equally applicable in the diagnosis of autonomic damage 
caused by other disorder 28,29. 
 Variables Influencing  CAN testing  
            1)  Time of the day  
  2)  Metabolic Status 
  3)  Coffee & Smoking Avoidance 
  4)  Presence of Cardiovascular disease & drugs 
  5)  Posture - Standing  and sitting reduces HRV 
 
In our study we used the Ewings battery of cardiovascular tests to detect 
cardiac autonomic neuropathy:   The tests can be divided in to 
A  Tests reflecting cardiac parasympathetic damage: 
1.Heart rate response to Valsalva manoeuvre. The Valsalva manoeuvre is 
a much more complex reflex arc involving sympathetic and parasympathetic 
pathways to the heart, sympathetic pathways to the vascular tree, and 
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baroreceptors in the chest and lungs.25 There are four phases in valsalva  
cardiovascular  responses include  
♦   Phase I      Rise in BP 
♦   Phase II    ↓ in BP ; Tachycardia. 
♦   Phase III    Fall in BP 
♦   Phase IV    Overshoot of BP; Bradycardia 
During the strain period of the valsalva manoeuvre the blood pressure 
drops and heart rate rises. After release the blood pressure rises, 
overshooting its resting value, and the heart slows. The heart rate response in 
valsalva is mediated by vagus nerve29. In patients with autonomic 
neuropathy the blood pressure slowly falls during the strain and slowly 
return to normal after the release, with no overshoot rise in blood pressure 
and no change in heart rate. The test was performed by the patient blowing 
into a mouth piece connected to a sphygmomanometer and holding it at a 
pressure of 40 mm Hg for 15 seconds while a continuous ECG was 
recorded. The manoeuvres performed 3 times with interval of one minute in 
between. The result was expressed as the Valsalva ratio30 which is the ratio 
of the longest R-R interval after the manoeuvre (reflecting overshoot 
bradycardia following release) to the shortest R-R interval during the 
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manoeuvre.(reflecting the tachycardia during strain) The mean of three 
Valsalva ratio was taken as the final value 
 
 
 
 
 
 
 
2) Heart rate variation during deep breathing 
Normally the heart rate varies continually but it depends upon intact 
parasympathetic nerve supply. Patients with autonomic neuropathy may 
have a noticeable reduction in and sometimes complete absence of heart-rate 
variation. Reduced heart rate variability is the earliest indicator of 
cardiovascular autonomic neuropathy 31 
Autonomic imbalance associating increased sympathetic activity and 
reduced vagal tone has been been strongly implicated in the pathophysiology 
of arrhythmogenesis and sudden cardiac death. Among the different 
available noninvasive techniques for assessing the autonomic status heart 
          VALSALVA RATIO   POINTS 
    >1.21     Normal     0 
1.11 - 1.20 Borderline    0.5 
    <1.10.  Abnormal     1 
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rate variability (HRV) has emerged as a simple, non invasive method to 
evaluate the sympathovagal balance at the sinoatrial level.32 and as a clinical 
tool for screening and identifying patients particularly at risk for cardiac 
mortality.32 
The patient sits quietly and breathes deeply at 6 breaths a minute (five 
seconds in and five seconds out) for one minute. Deep breathing at six 
breath per minute is the most convenient and reproducible technique 19 An 
electrocardiogram was recorded throughout the period of deep breathing 
with a marking done  to indicate the onset of each inspiration and expiration. 
The maximum and minimum RR intervals during each breathing cycle were 
measured and converted into beats/minute. The result was then expressed as 
the mean of the difference between maximum and minimum heart rates for 
the 6 measured cycles in beats a minute 
 
 
 
 
 
 
HEART RATE VARIATION DURING  
DEEP BREATHING 
 
    POINTS 
 
> 15 beats / minute normal response       0 
11-14 beats / minute, borderline       0.5 
< 10 beats / minute. abnormal response        1 
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3)   Immediate heart rate response to standing ( 30:15 ratio) 
                During the change from lying to standing a characteristic 
immediate rapid increase in heart rate occur which is maximal at about the 
15th beat after standing. A relative overshoot bradycardia then occur, 
maximal at about the 30th beat. This response is mediated by vagus nerve. 
Patients with autonomic neuropathy show only a gradual or no increase in 
heart rate after standing. 
The test was performed with the patient lying quietly on a couch while 
heart rate was recorded continuously on ECG machine. The patient was 
asked to stand up unaided and the point at starting to stand was marked on 
ECG. The shortest R-R interval at or around the 15th beat and largest R-R 
interval at or around the 30th beat after starting to stand  were measured with 
a ruler. The characteristic heart rate response was expressed by 30:15 ratio, 
values are as follows 
 
 
 
 
 
 
IMMEDIATE HEART RATE 
RESPONSE TO STANDING 
    POINTS 
          > 1.04      Normal         0 
        1.01- 1.03      Borderline        0.5 
          < 1.00      Abnormal         1 
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B)               Tests reflecting sympathetic damage: 
       1)     Blood pressure (BP) to standing 
                                    On standing pooling of blood in the legs causes a fall 
in blood pressure ,which is normally rapidly corrected by peripheral 
vasoconstriction29 In patients with autonomic neuropathy the blood pressure 
falls on standing and remains lower than in lying position. The test was 
performed by measuring the patients BP while he was lying down quietly 
and again when he stood up. The postural fall in BP was taken as the 
difference between systolic BP lying and the systolic BP standing values are 
given below  
 
 
 
 
 
 
 
 
 
 
SYSTOLIC BLOOD PRESSURE   
FALL ON STANDING 
POINTS 
 
           <10        Normal 0 
         11-30        Boderline 0.5 
            >30        Abnormal 1 
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2) Blood pressure response to sustained hand grip 
  During sustained handgrip a sharp rise in blood pressure occurs , due 
to a heart rate dependant increase in cardiac output with unchanged 
peripheral resistance. In patients with autonomic neuropathy,  rise in 
diastolic blood pressure is abnormally small. The maximum voluntary 
contraction is first determined using a handgrip dynamometer. Handgrip is 
then maintained at 30% of that maximum for as long as possible up to 3 mts. 
Blood pressure is measured three times before and at one minute interval 
during handgrip. The result is expressed as the difference between the 
highest diastolic blood pressure during hand grip exercise and the mean of 
the three diastolic blood pressure reading before  handgrip began 
 
INCREASE IN DIASTOLIC BP 
DURING SUSTAINED HANDGRIP 
POINTS 
         >15 mmof Hg         Normal       0 
     15-10 mm of Hg         Boderline      ½ 
        <10  mmof Hg         Abnormal       1 
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RESULTS OF CARDIOVASCULAR REFLEX TEST 
The total points from each of these five tests are added together and the 
cardiac autonomic neuropathy score calculated (CAN score). Based on the 
CAN SCORE categorized as follows:  
 
 
 
 
 
 
 
 
 
           
 
 
 
 
           CAN SCORE      TOTAL POINTS 
0   or   ABSENT CAN              0 
1  or    EARLY CAN          0.5-1.5 
2  or    DEFINITE CAN            2-3 
3  or    SEVERE CAN          >3.5 
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AIM OF THE STUDY 
 
1) To study the prevalence of cardiac autonomic neuropathy in patients 
with Rheumatoid arthritis 
2) To study the correlation between cardiac autonomic neuropathy and  
Age, Sex, Duration of disease, Rheumatoid factor positivity and the 
DAS 28 score. 
 
 
 
 
 
 
 
38 
 
MATERIALS 
Fifty three  patients  (15 males, 38 females) with rheumatoid arthritis 
who attended the outpatient department of rheumatology, Madurai Medical 
College were included as the study population. Twenty nine age and sex 
matched persons were taken as controls. This is a  cross-sectional- case 
control study conducted for a period of 6 months . The study patients were 
below 60 years of age so that the neurological problems due to ageing was 
minimized .After detailed history, clinical examination and lab 
investigations, other causes of autonomic neuropathy were excluded and 
then cardiac autonomic reflex test done .All patients were able to perform  
cardiac autonomic reflex test . Few patients had difficulty in exerting 
maximum hand grip in dynamometer. But they were able to achieve 30% of 
the maximum hand grip for the age and sex matched control. The controls 
were selected from the healthy relatives of the patients and those attended 
OPD with minor ailments like URTI. Informed consent taken from both 
patients and control before assigning them to study 
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Inclusion criteria 
Patients who fulfilled 1987 revised AMERICAN RHEUMATOLOGY 
ASSOCIATION criteria for rheumatoid arthritis. 
Exclusion criteria 
1) Age above 60 years  
2) Endocrine and Metabolic disorders like Diabetes and Electrolyte    
          imbalance like Hyponatremia and Hypokalemia 
3) Hypertension 
4) Liver, Renal, Respiratory and Cardiac diseases 
5) Pregnancy 
 6) Severe anemia 
7) Treatment with drugs influencing the adrenergic nervous system like 
beta blockers, antiarrhythmic agents, diuretic, adrenergic inhibitor, 
vasodilator, sedative, hypnotic and antiepileptic drugs were also excluded 
from the study. 
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8) Cardiac disease like CAD, CCF, arrythmias, cardiomyopathy, volume   
overload status 
9) Presence of central or peripheral nervous system disease  CVA, leprosy 
10) Presence of any other disease that affects the ANS like hypothyroidism, 
amyloidosis, systemic lupus erythematosis, multiple myeloma 
 
METHODS 
All the selected patients were subjected for detailed clinical 
examination.   
Hematological evaluation included complete hemogram,  
Biochemical parameters including blood urea, serum creatinine, serum 
sodium, serum potassium, Liver function test, TFT, Random blood sugar 
 Immunological evaluation included Rheumatoid factor and CRP by latex 
agglutination method. 
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                          Cardiac autonomic neuropathy testing. 
Five  standard cardio vascular autonomic reflex tests (Ewings et al ,1970)(4) 
which  assess the integrity of sympathetic and parasympathetic system on 
cardiovascular system  were done..These tests include  
1. Heart rate response to deep breathing (E/I ratio) 
2. Heart rate response to valsalva manoeuvre 
3. Immediate heart rate response to standing(30:15) 
4. Blood pressure response to sustained handgrip 
5. Blood pressure response to standing 
       First three tests assessed parasympathetic system and the rest two 
assessed sympathetic function. Parasympathetic system assessment done by 
taking continuous ECG monitoring with 8-channel PSYCO-PHYSIOPAC 
software and by calculating the heart rate and ratio by using the standard 
guidelines as described below.  Sympathetic system assessed by measuring 
the blood pressure in standing and sustained hand grip using dynamometer 
and mercury manometer. 
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TEST PROTOCOL 
Tests were done during the morning hours  
Tobacco, Alcohol were not allowed before the test  
Patients were asked to relax in a quiet room for at least 10 minutes before 
testing. Then tests were conducted, in the following order. First supine BP is 
measured and maximum power  in dynamometry assessed, then  ECG limb 
leads  connected   and continous ECG recording done at lead 2 in 8-channel 
psyco-physiopac software. Time is noted  separately during the start of each 
phase like beginning and ending point of inspiration ,beginning of strain 
phase of valsalva and release phase,30th and 15th beat after immediate 
standing etc, so as to calculate heart rate at various phases. Recording done 
at first during normal breathing for 30 seconds, then deep breathing for one 
minute, then instructed to take normal breathing again for 30seconds,  after 
this   valsalva  manoeuvre done as described in further section. After 
valsalva manoeuvre is over, patient  takes  normal breathing for 30 seconds  
and then asked to stand immediately. Once 30th QRS complex is over in 
ECG recording after standing, recording is stopped .Then Blood pressure 
measured  at 3rd minute of standing from supine position. (Recording at 
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normal breathing done in between to get a stable base line heart rate between 
each events) .Then patient lies in supine position, Blood pressure measured, 
and after one minute  hand grip BP measured  by using grip dynamometer 
with 30% of maximum power.  
1.HEART RATE RESPONSE TO DEEP BREATHING  
          The patient is made to lie in supine position quietly and breathe at the 
rate of six breaths per minute for one minute. ECG is recorded throughout 
the period of deep breathing, with time noted separately  to indicate the 
onset of each inspiration and expiration using 8-channel psyco-
physiopac.The maximum and minimum heart rate during each breathing 
cycle is measured. The result is then expressed as the mean of the difference 
between maximum and minimum heart rate for the six measured cycles. 
 2. HEART RATE RESPONSE TO VALSALVA MANOEUVRE 
           The patient is asked to blow in to the rubber tubing of the 
sphygmomanometer and hold it at pressure of 40 mm of mercury for 
15seconds while continuous ECG was recorded. Then the patient was asked 
to breathe normally with continuous ECG monitoring. The manoeuvre is 
perfomed thrice, with one minute interval in between them. Then valsalva 
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ratio is calculated, which is the ratio of the  maximum heart rate during the 
release phase to the minimum  heart rate during the straining phase . 
3. IMMEDIATE HEARTRATE RESPONSE TO STANDING 
  The test is performed with the patient lying quietly, while a 
continuous ECG being recorded. The patient is  then asked to  stand up 
immediately and the starting time  of standing is noted separately. the 
shortest RR interval at or around the 15th beat and the longest RR interval at 
or around the 30th beat after standing are measured .The result is expressed 
as the ratio of RR interval of 30th  to 15th  (30:15 ratio)  
4. BLOOD PRESSURE RESPONSE TO STANDING 
  Measuring patient’s blood pressure twice, first in  lying posture and 
the second  at standing .The standing blood pressure is taken after an interval 
of three minutes of standing. The blood pressure response is the difference in 
systolic pressure on lying and on standing. The test is repeated thrice and the 
average of 3 values is taken into account 
5 BLOOD PRESSURE RESPONSE TO SUSTAINED HANDGRIP 
  The maximum voluntary contraction of hand is determined using grip 
dynamometry initially and the hand grip test is done by  maintaining  the 
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grip at 30% of the maximum up to three minutes using dynamometer. The 
result is expressed as the difference between the highest diastolic blood 
pressure during the hand grip and the normal diastolic blood pressure before 
the hand grip. 
          The results of each of the above five tests are classified into three 
separate groups based on the severity of abnormality detected, and each of 
them is given a definite point as described by Bellavere et al. 
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TABLE:1      DETERMINATION OF CAN SCORE 
 
 
Autonomic function test  Points
1 Heart rate variability on deep breathing  
   >15 beats/min 0 
11-15 beats/min        
1/2 
  <11 beats/min 1 
2. Postural hypotension      (fall in systolic blood pressure)  
    <10 mm Hg 0 
   11-29 mm Hg 1/2 
   >30 mm Hg  1 
3. Valsalva ratio (longest RR interval: shortest RR interval)  
  >1.2  0 
  1.2–1.10  1/2 
  <1.10  1 
4. Heart rate variability on standing(30:15)  
   >1.04 0 
   1.01-1.03  1/2 
   <1   1 
5. Increase in diastolic blood pressure during sustained handgrip  
  >15 mm Hg  0 
  15–10 mm Hg  1/2 
  <10 mm Hg  1 
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The total points from each of these five tests are added together and the 
cardiac autonomic neuropathy score calculated (CAN score). Based on the 
CAN SCORE categorized as follows:  
 
 
 
 
 
 
DAS 28 score  
Disease activity score is a composite score using tender and swollen 
joint count, ESR and patient’s global assessment activity using a 10 mm 
visual analogue scale.  
         DAS28= 0.56 √(tender joints) + 0.28√(swollen joints) 
                         + 0.70 Log (ESR) + 0.014(VAS in mm) 
 
           CAN SCORE      TOTAL POINTS 
0   or   ABSENT CAN              0 
1  or    EARLY CAN          0.5-1.5 
2  or    DEFINITE 
CAN 
           2-3 
3  or    SEVERE CAN          >3.5 
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Classification  
          Less Active  ≤ 3.1 
Moderate 3.2- 5.1 
Highly active > 5.1     
(Minimum score= 0; Maximum score= 9) 
 
STATISTICAL ANALYSIS 
Statistical Tools   
The information collected regarding all the selected cases were 
recorded in a Master Chart. Data analysis was done with the help of 
computer using Epidemiological Information Package (EPI 2008).  
 Using this software, range, frequencies, percentages, means and  
standard deviations  and p value were calculated.  
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RESULTS AND ANALYSIS 
A total of 53 patients were evaluated.All of the patients are from 
Madurai district only. The male : female ratio is 1:2.5. The mean age is 
40.5±7.7years. Mean duration of the disease was 6.51±3.52 yrs.  
Out of 53 patients,  four patient had postural dizziness (1 male and 3  
female) 
Laboratory evaluation showed,  
Hb ranges from  10 gm% to 12.6 gm%, with Mean Hb of 10.96± 0.64gm%. 
ESR ranges from 25-120 mm with mean of 63.3±27.8 mm/ 1st hr 
Rheumatoid factor (RF) was positive in 39 (73.6%) patients..  
CRP Positive  in 35 (66.1%).  
DAS 28 was in the range of 3-8.26 with a mean of 6.5. 
  Out of 53 patients who were subjected for autonomic nervous system 
tests, 18 (34%) patients had CAN score ൒2 ie, DEFINITE CAN.  
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PROFILE OF PATIENTS WITH DEFINITE CARDIAC 
AUTONOMIC NEUROPATHY ARE AS FOLLOWS, 
 Fourteen patients were females and four were males. 
 The mean age was 41.4±7.6 years.  
The mean disease duration was 6.8±3.9 yrs.  
The Mean Hb  is 10.94±0.53gm%.  
The mean DAS 28 score was 6.5±1 was there in can positive patients. 
 RF positivity is present in  13 patients and 12 patients is having   CRP 
positivity. 
The mean ESR  is 68.9±31.4mm/hr.  
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PROFILE OF CASE STUDIED 
Table 1  Sex Distribution Among Cases And Control 
  
There is no statisticallty significant relation ship between sex distribution 
among cases and control ( p= 0.8491) 
Table 2  Age Distribution In  Cases And Control 
AGE IN 
YEARS 
                    CASES                CONTROL 
NO % NO % 
<30 4 7.5 5 16.1 
30-39 19 35.8 12 38.7 
40-49 23 43.4 10 32.3 
50 &  
ABOVE 
7 13.2 4 12.9 
TOTAL 53 100 31 100 
RANGE 21-56 25-58 
MEAN 40.5 38.8 
SD 7.7 8.7 
P VALUE                            0.2837 NOT SIGNIFICANT 
       Mean age is 40.5 among cases, and 38.8 among control. There is no 
statistically significant relation ship between age distribution among cases 
and control ( p =  0.2837) 
 
SEX CASES CONTROL 
NO % NO % 
MALE 15 28.3 10 32.3 
FEMALE 38 71.7 21 67.7 
TOTAL 53 100 31 100 
P VALUE                       0.8491  NOT SIGNIFICANT 
52 
 
Table 3 Quantitative Parameters 
MEAN DAS28 IS 6.28 
Mean duration is 6.62years 
 
Table 4(a) Qualitative Parameters 
 
PARAMETER POSITIVE  NEGATIVE 
NO % NO 
 
% 
RF 39 73.6 14 26.4 
CRP 35 66.1 18 33.9 
 
Among the 53 cases 39 were Rheumatoid factor positive and 35 were CRP 
positive. 
 
 
 
PARAMETER RANGE MEAN SD 
DURATION 1-15yrs 6.62 3.74 
HB 10-12.6 10.96 0.64 
ESR 25-120 63.3 27.8 
DAS28 3-8.26 6.28 1.31 
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Table 4(b): Disease Duration Among Cases 
       Duration Cases 
 NO % 
           0-5 23 43.4 
          6-10 22 41.5 
         10-15 8 15.1 
        TOTAL 53 100 
 
Most  of the patients are in the  disease  duration category of 0-10 years . 
 
 
Table 4(C): Das 28 Distribution Among Cases 
DAS28 SCORE NO: OF PATIENTS
≤3 1 
3.1-5 11 
>5 41 
 
Majority   of the cases  ie, 77 %  in our study comes   under the  DAS28 
category is >5 
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Table 5: can score distribution 
CAN SCORE CASES 
NO % 
NO CAN 4 7.5 
EARLY CAN 31 58.5 
DEFINITE CAN 18 34 
TOTAL 53 100 
 
Among 53 cases 18 (34%) had DEFINITE  CARDIAC  AUTONOMIC 
NEUROPATHY 
Table 6 Definite CAN And Age Group 
AGE 
GROUP 
TOTAL                                           DEFINITE CAN 
POSITIVE NEGATIVE 
NO % NO % 
<30 4 1 25 3 75 
31-40 19 6 31.6 13 68.4 
41-50 23 9 39.1 14 60.9 
>50 7 2 28.6 5 71.4 
TOTAL 53 18 34 35 66 
MEAN 41.4 40 
SD 7.6 7.8 
P 
VALUE 
O.5916 NOT SIGNIFICANT 
Most of the definite cardiac autonomic neuropathy patients comes under the 
age group of 41-50  ie (39.1%) but p =  0.596 , suggesting that definite can 
and age  has no statistically  significant relation. 
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Table 7  Definite Can And Sex 
SEX TOTAL DEFINITE CAN 
POSITIVE NEGATIVE 
NO % NO % 
MALE 15 4 26.7 11 73.3 
FEMALE 38 14 36.8 24 63.2 
TOTAL 53 18 35 
P VALUE 0.702   NOT SIGNIFICANT 
Most of the definite cardiac autonomic neuropathy patients are ie (39.1%) 
females. but p = 0.702, suggesting that definite can and sex has no 
statistically  significant relation. 
Table 8  Definite CAN and duration of disease 
DURATION 
OF 
DISEASE 
TOTAL NO 
AMONG 
EACH 
DURATION 
SCALE 
DEFINITE CAN 
POSITIVE NEGATIVE 
NO % NO % 
<5 18 7 38.9 11 61.1 
5-10 27 8 29.6 19 70.4 
>10 8 3 37.5 5 62.5 
TOTAL 53 18 34 35 66 
MEAN  6.8 YEARS 6.5 YEARS 
S.D  3.9 YEARS 3.7 YEARS 
P VALUE 0.88 NOT SIGNIFICANT 
 
For definite cardiac autonomic neuropathy and duration of illness p = 0.88, 
suggesting that definite can and duration of disease has no statistically   
significant  relation. 
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Table 9:  Definite CAN And RF 
RF NO. OF 
CASES 
DEFINITE CAN 
POSITIVE NEGATIVE 
NO % NO % 
POSITIVE 39 13 33.3 26 66.7 
NEGATIVE 14 5 35.7 9 64.3 
P VALUE 0.5596 NOT SIGNIFICANT 
For definite cardiac autonomic neuropathy and RF positivity p = 0.5596, 
suggesting that definite can and   RF positivity   has no statistically 
significant  relation. 
Table 10  Definite CAN And CRP 
CRP NO. OF 
CASES 
DEFINITE CAN 
POSITIVE NEGATIVE 
NO % NO % 
POSITIVE 35 12 34.3 23 65.7 
NEGATIVE 18 6 33.3 12 66.7 
P VALUE 0.8127 NOT SIGNIFICANT 
For  definite cardiac autonomic neuropathy and CRP positivity p = 0.8127, 
suggesting that definite can and  CRP positivity   has no statistically  
significant  relation 
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Table 11 Definite CAN And DAS28 
DAS 28 DAS28 
POSITIVE NEGATIVE 
NO % NO % 
<3 0 0 1 2.9 
3.1-5 2 11.1 9 25.7 
>5 16 88.9 25 71.4 
TOTAL 18 34 35 66 
MEAN DAS 
28 
6.5 6 
S.D 1 1.3 
P VALUE 0.62 NOT SIGNIFICANT 
For  definite cardiac autonomic neuropathy and DAS28 p = 0.62. suggesting 
that definite can and DAS28 has no statistically   significant  relation. 
Table 12 Definite  And HB 
PARAMETER AVERAGE VALUE IN P VALUE 
CAN POSITIVE CAN NEGATIVE 
MEAN ± SD MEAN ± SD 
HB 10.94  ±0.53 10.97 ± 0.7 0.8279 NOT 
SIGNIFACANT 
 
For definite cardiac autonomic neuropathy and Hb p = 0.8279.  suggesting 
that definite CAN and Hb has no statistically significant  relation. 
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Table 13 Ewings Battery Of Test Results In Patients And Control 
PARAMETER STUDY CONTROL P VALUE 
MEAN±SD MEAN±SD 
HR REST 79.9 ± 8.5 75.5±  4.9 0.0272 
HR DB 
MAXIMUM 
89.6±8.8 90±5.5 0.7872 
HR DB 
MINIMUM 
77.5±9.5 68.1±4.6 0.0001 
HR 
VARIABILITY 
12.1±6.9 21.9±3.7 0.0001 
VAL MAX 99±11.7 98.1±4 0.6283 
VAL MINI 76.4±9.4 66.1±4.4 0.0001 
VAL RATIO 1.31±0.19 1.49±0.09 0.0001 
30:15 1.03±0.06 1.08 ±0.02 0.0367 
SYSTOLIC FALL 
IN BP ON 
STANDING 
11.06±6.76 7.94 ± 3.67 0.048 
HAND GRIP DBP 
DIFFERENCE 
11.68±6.23 17.23±2.72 0.0001 
Heart rate variability during deep breathing, Valsalva ratio, and rise in 
diastolic BP during  sustained hand grip   are more significantly  decreased  
in the study 
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DISCUSSION 
A total of 53 patients were evaluated in our study. All of the patients 
are from in and around Madurai district only. The  Male : Female ratio is  
1:2.5. The mean age is 40.5±7.7 years. Mean duration of the disease was 
6.51±3.52 yrs. Out of 53 patients  four patient had postural dizziness (1 male 
and 3  female) 
Laboratory evaluation showed,  
Hb ranging from  10 gm% to 12.6 gm%, with Mean Hb of 10.96± 
0.64 gm%. ESR ranging  from 25-120 mm with mean of 63.3±27.8 mm/ 1st 
hr Rheumatoid factor (RF) was positive in 39 (73.6%) patients..  
CRP was positive  in 35 (66.1%).  
DAS 28 was in the range of 3-8.26 with a mean of 6.5. 
    Out of 53 patients who were subjected for autonomic nervous system 
tests, 18 (34%) patients had CAN score ൒2  so they were assigned under 
DEFINITE CAN  in the Bellavere modification of  Ewings test category. 
  
60 
 
            Profile of patients with DEFINITE CAN  in our study 
M : F            4:14 
MEAN AGE           41.4±7.6 years 
MEAN DISEASE DURATION            6.8±3.9 yrs. 
RHEUMATOID  FACTOR  +ve           13 patients 
CRP +ve           12 patients 
MEAN DAS28            6.5±1 
MEAN Hb           10.94±0.53gm%.  
MEAN ESR           68.9±31.4mm/hr 
 
The results were analysed and DEFINITE CAN group were correlated with 
age of the patient ,sex of patient ,disease duration and Rheumatoid factor 
positivity and disease severity score( DAS28)  
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CAN correlation with various parameters 
         P value  
CAN and AGE      0.5916          not significant 
CAN  and SEX      0.702        not significant 
CAN and DURATION OF 
DISEASE 
     0.88         not significant 
CAN  
and RHEUMATOID FACTOR 
POSITIVITY 
     0.5596       not significant 
CAN and DAS 28       0.6           not significant 
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Our study shows that 34% ( ie 18 patient out of 53 RA patients) of 
rheumatoid arthritis have cardiac autonomic neuropathy. Among patients 
with cardiac autonomic neuropathy only four patient (22%) have symptoms 
of cardiac autonomic neuropathy  and the remaining ie, 14 patients (78%) of 
them are asymptomatic. Correlating our study results with the age ,sex, 
duration of disease,DAS28, rheumatoid factor positivity and CRP , it was 
found that there is no statistically significant relationship between CAN and 
these parameters. Among the reflex tests  valsalva ratio, and 
Expiration:inspiration ratio and diastolic BP in handgrip had the high 
significance value. 
Similar studies conducted in various centers showed  little variation in 
the percentage of cardiac autonomic neuropathy in the study population but 
uniform finding in these studies is that cardiac autonomic neuropathy has no 
statistically significant relationship with age, sex, duration of disease, 
rheumatoid factor positivity or DAS 28. 
LOUTHRENOO, et al studied CAN IN RA among 34 RA patients33 
with M:F  1:7.5, age group were 47.2±10.5 and duration of disease was  
5.1±3.61 This study  used standard  Ewings test for assessing the cardiac 
autonomic status .  .In this study 47% of the RA Patients have diminished 
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cardiovascular ANS responses  .It showed no correlation to  number of 
Swollen joints, ESR ,RF titre or Duration of disease. 
V. Sandhu et al studied about Attenuated cardiovascular reflexes in  
established RA,in  62 patients with 41 healthy age and sex matched control. 
In this study age was  38±8.4yrs34. .This study showed that Valsalva ratio, 
Heart rate variation during deep breathing, 30:15 ratio, Diastolic blood 
pressure response to hand grip were significantly decreased in rheumatoid 
arthritis patient.  
The following are the p value for the standard cardiovascular test The 
Valsava ratio (VR)(p=0.03),The heart rate variation during deep breathing 
(HRV) was (p=0.01),The 30:15 ratio in entire RA cohort (p=0.001) . The 
diastolic blood pressure response to hand grip in RA patients (p=0.001), No 
abnormalities were found in the systolic blood pressure response to standing. 
In RA patients in this study, the lowest values for VR, HRV and 30:15 were 
recorded in those with disease of greater than 10 years duration. However, 
on multivariate analysis, neither age nor duration of disease nor 
seropositivity35 was found to be an independent variable predicting impaired 
cardiovascular reflexes 
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In a study conducted by Toussirot E et al38.cardiac autonomic 
dysfunction was reported to be 60%. who demonstrated that 60% of their 50 
RA patients had ANS dysfunction, defined by abnormal results on two of the 
three cardiovascular reflex tests. However, ANS dysfunction showed no 
correlation with the Duration of the disease, Inflammatory syndrome, RF 
titre or Articular destruction. 
 In Carşamba Government Hospital, Turkey, M. Aydemir et al studied 
cardiac autonomic profile in rheumatoid arthritis in 26   RA  patients36 with 
40 healthy controls.  Autonomic nervous system dysfunction was 
determined according to classical Ewing autonomic test battery and 
modified Ewings criteria . Both the classical and modified Ewing test 
batteries have revealed that the frequencies of autonomic neuropathy were 
significantly higher in patient groups compared with controls (p < 0.001). . 
No relation was found between autonomic neuropathy and disease duration, 
disease activity and autoantibody positivity. 
 
Bidikar MP37   et al  j studied  sympathetic nervous system involvement in 
fifty rheumatoid arthritis patient between age group of 20 to 60 yrs by using 
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standard test and found out that 26% of rheumatoid arthritis patient had 
sympathetic dysfunction  
Maule et al.,6 also showed impaired autonomic nervous function in patients 
with    RA. They reported  that auto antibodies directed against autonomic 
nervous system structures  might play a role in the pathogenesis of the 
autonomic dysfunction.6 
Tan et al.39 also found abnormal heart rate response to deep breathing 
in eight of their 30 RA patients (27%). Five of these eight had had clinical 
symptoms of dysautonomia. 
Edmonds et al40demonstrated abnormalities in parasympathetic 
cardiovascular reflexes in nine of their 27 RA patients (33%). 
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SUMMARY 
 The  study on “CARDIAC AUTONOMIC NEUROPATHY   IN 
RHEUMATOID ARTHRITIS” is a cross sectional–case control study 
conducted on patients visiting outpatient Department of Rheumatology, 
Government Rajaji Hospital,Madurai. 
           Our aim was to study the prevalence of CARDIAC AUTONOMIC 
NEUROPATHY in rheumatoid arthritis and to correlate with the AGE, 
SEX, DURATION OF ILLNESS, RHEUMATOID FACTOR POSITIVITY, 
CRP, and DAS28 SCORE. 
Fifty three patients  with rheumatoid arthritis and twenty nine age and 
sex matched control were studied. Cardiac autonomic function test is done 
by EWINGS STANDARD CARDIOVASCULAR REFLEX TEST and 
scoring done according to Bellevare modification of Ewings criteria. 
 The information collected regarding all the selected cases and control 
were recorded in a master chart and data analysis done with the help of  
Epidemiological Information Package ( EPI 2008) 
Analysis of data shows that DEFINITE CARDIAC AUTONOMIC 
NEUROPATHY (CAN) ie., at least two abnormal test in the EWINGS 
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STANDARD CARDIOVASCULAR TEST, was present in 18 (34%) 
patient. On correlating DEFINITE CAN positive patients data with the Age, 
Sex, Duration of illness, RF positivity, DAS 28 and CRP, it was found that 
there is no statistically significant correlation between DEFINITE CAN and 
these parameters. 
Our study had only 53 patients and a study on larger population could 
throw more light on the cardiac autonomic neuropathy in rheumatoid 
arthritis   
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CONCLUSION 
• Cardiac autonomic neuropathy is a common manifestation in patients 
with rheumatoid arthritis  
• More than 3/4th of the cardiac autonomic neuropathy are 
asymptomatic 
• Cardiac autonomic neuropathy has no relation with age, sex, 
seropositivity, duration of illness or DAS 28 
• This study emphasizes the need for an early screening for cardiac 
autonomic neuropathy  in rheumatoid arthritis to avoid morbidity and 
mortality and to anticipate cardiovascular responses in procedures like 
general anaesthesia and surgical procedures  
  
 
 
 
 
          
          
 
 
 
RESEAR
          M
CH LA
ADUR
B –INST
AI MED
ITUTE 
ICAL C
OF PHY
OLLEGE
SIOLOG
 
Y  
 
  
 
         P
 
 
 
 
 
HYSIOLAB ‐‐ 8‐channel PSYCO‐PHYSIOPAC   
 
  
 
 
 
 
 
 
GRIP DYNAMOMETER
 
  
 
          
1) BP
3) ECG
      MA
 APPAR
 RECO
TERIAL
ATUS. 
RDING
S USED
      
.       
 FOR  C
2) STET
4) GRIP
AN TES
HESCO
 DYNA
TING 
PE.       
MOME
     
TER 
 
0%
20%
40%
60%
80%
100%
2
4
6
8
10
S
A
0%
0%
0%
0%
0%
0%
L
ex  Distri
ge Distri
STUDY
1
3
STUDY
ess than 30 y
Gr
bution am
Gr
bution am
 GROUP
5
8
FEM
 GROUP
4
19
23
7
rs 30 -
aph- 1   
ong case
 
 
aph- 2   
ong cases
ALE
39 40 
s and cont
 and cont
MALE
- 49 50
rols          
rols          
CONTROL 
GROUP
10
21
CONTROL 
GROUP
5
12
10
4
 Above
 
 
 
 
 
 
RF
CRP
0%
C
20%
p
Gr
Qualitativ
RP and R
40%
39
35
ositive
 
 
 
 
 
 
 
aph- 3   
e parame
F among 
60%
ters   
cases   
80
negative
% 1
14
18
00%
 
 
 
 
 
 
 
 
 
 
 
 
Dis
DAS
42%
0-5 yrs
77%
Gr
Qualitativ
ease durat
Gr
28 distrib
DAS2
aph- 4   
e parame
ion amon
aph- 5   
ution amo
6-10 yrs
2%
2
8 SCORE
ters   
g cases  
ng cases  
43%
15%
11
1%
 
-15 yrs
≤3
3.1‐5
>5
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
N
DAS
Definit
O CAN
Gr
28 distrib
Gr
e CAN an
58%
EARLY
aph- 6   
ution amo
 
 
aph- 7   
d Age Co
8%
 CAN
ng cases  
mparison
DEFINI
 
 
34%
TE CAN
 
 
 
 
 
 
 
Graph- 8   
Definite CAN and Sex Comparison 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CC
AN POS
AN NEGA
CAN PO
CAN NE
Defini
Definit
0%
ITIVE
TIVE
SITIVE
GATIVE
Gr
te CAN a
Gra
e CAN an
20%
1
Rh
POSITIV
0% 20%
1
POSITI
aph- 9   
nd RF Co
 
ph- 10   
d CRP Co
40%
3
26
eumafact
E NEG
40%
2
23
CRP
VE NEG
mparison
mparison
60%
or 
ATIVE
60% 80
ATIVE
 
 
80%
5
9
% 100%
6
12
100%
 
 
 
 
 
 
 
 
Graph- 11   
 
Comparison of DAS 28 distribution among 
 definite CAN patients and cases 
 
 
 
BIBILIOGRAPHY 
 
1. Gabriel SE,Crowson CS,O’Fallen WM.The epidemiology of rheumatoid 
arthritis in Rochester,Minnesota1955-1985.Arthritis Rheum 1999;42:415-
420. 
2. Harrissons principles of internal medicine 17 th edition chapter 314              
rheumatoid arthritis;peter E.lipsy page no;2083:2088 
3. Nepom GT,Byers P,Seyfried C et al:HLA genes associated with 
rheumatoid arthritis:Identification of susceptibility alleles using specific 
oligonucleotide probes.Arthritis Rheum 32:15,1989. 
4. Gary S .Firestein,Etiology and Pathogenesis of Rheumatoid 
arthritis.Kelley’s textbook of Rheumatology,seventh edition 65:996-1042. 
5. Salih AM, Nixon NB, Dawes PT, Mattey DL. J Rheumatol. Soluble 
adhesion molecules and anti-endothelial cell antibodies in patients with 
rheumatoid arthritis complicated by peripheral neuropathy .1999 
Mar;26(3):551-5. 
6. Autonomic nervous dysfunction in sle and    rheumatoid arthritis:               
possible pathogenic role of autoantibodies to autonomic  nervous system 
by s.maule quadri ,d.mirante et al,. Clin  exp immunol 1997; 110;423-427 
7. Arnett FC,Edworthy SM,Bloch DA et al .The American Rheumatism 
Association 1987 revised criteria for the classification of rheumatoid 
arthritis.Arthritis Rheum 1988; 31:315-324.\ 
8. Mc Gregor M:The significance certain measurements of the skull in the 
diagnosis of basilar impression.Br J Radiol,1948;21:171, 
9. Ranawat C,O’Leary P,Tsairis P:Cervical fusion in rheumatoid arthritis.J         
Bone Joint Surg Am  2001;83-A:194-200,.      
10. Fischgold H,Metzger J:Etude radiotomographique de I’impression 
basilaire.Rev Rheum Mal Osteoartic 1952;19:261, 
11. Boers M,Verhoeven AC,Markesse HM,et al:Randomised comparision of 
combination step-down prednisolone,methotrtexate,sulphsalazine with 
sulphasalazine alone in early rheumatoid arthritis.Lancet,   
1997;350(9074):309-318, 
12. Mottenen T,Hannonen P,Leirisalo-Repo M et al :Comparision of 
combination therapy with single drug therapy in early rheumatoid 
arthritis: a randomized trial.FIN RACO trial group.Lancet . 
1999;353(9164):1568-1573, 
13. Watkins PJ. Diabetic diarrhea, gastroparesis, and gustatory sweating. In:                    
Thomas PK, Asbury AK, et al, eds. Diabetic 
Neuropathy. Philadelphia: WB Saunders Co; 1987:199-200 
 
 
14.  Bharucha AE, Camilleri M, Low PA, Zinsmeister AR. Autonomic              
dysfunction in  gastrointestinal motilitydisorders. Gut. 
Mar 1993;34(3):397-401. [Medline]. 
15. Hilsted J., Galbo H., Christensen N.J. (1979)Diabetes, 28, 313-19. 
16. Dicou E, Hurez D, Nerriere V. Natural autoantibodies against the nerve               
growth factor in autoimmune diseases .   J Neuroimmunol 1993; 47:159–
68. 
17. Pfeifer M.A. (1990) Diabetes Spectrum, 3, 45-48. 
18. Pfeifer MA: Cardiovascular autonomic neuropathy: advances in testing           
help unlock its complexity. Diabetes Spectrum 3:45-48, 1990. 
19. Ewing D J Borsey DQ Bellevere F ,Clarke BF.CARDIAC AUTONOMIC  
NEUROPATHY IN DIABETES- comparition of measures of R-R 
interval variation,diabetologia 1981;21;18-24 
20. Sampson MJ, Wilson S, Karagiannis P, Edmonds M, Watkins PJ:       
Progression of diabetic autonomic neuropathy over a decade in insulin-  
dependent diabetics. Quart J Med 75:635-46, 1990.  
21. Aronson D: Pharmacologic modulation of autonomic tone: implications 
for the diabetic  patient. Diabetologia 40:476-81, 1997.  
22. American Diabetes Association: Consensus statement: Autonomic 
nervous system testing. Diabetes Care 15 (Suppl 3):1095-1103, 1992. 
23. Ewing D.J., Boland O., Neilson J.M., Cho C.G.,Clarke B.F. (1991) 
Diabetologia, 34, 182-185. 
24. Kahn J.K., Zola B., Juni J., Vinik A. (1986)Diabetes Care, 9, 389-94. 
25. American Diabetes Association: Consensus statement: Autonomic 
nervous system testing. Diabetes Care 15 (Suppl 3):1095-1103, 1992. 
26. Clinical autonomic testing report of the Therapeutics and Technology 
Assessment Subcommittee of the American Academy of Neurology: 
assessment. Neurology 46:873-80, 1996. 
27. Vanninen E, Uusitupa M, Lansimies E, Siitonen O, Laitinen J: Effect of 
metabolic control on autonomic function in obese patients with newly 
diagnosed type 2 diabetes. Diabetic Med 10:66-73, 1993.\ 
28. Clarke BF,EwingDJ,CAMPBELL IW.DIABETIC AUTONOMIC     
NEUROPATHY DIABETOLOGIA 1979;17;195-212 
29. Ewing d j. Cardiovascular reflex and utonomic neuropathy.clin.sci mol 
med      1978;55;321-7 
30. Levine AB.A simple test of cardiac function based upon the heart rate 
change induced by the valsalva maneuver.AM J CARDIOL 1966;18;90-9 
31. Pfeifer MA: Cardiovascular autonomic neuropathy: advances in testing 
help unlock its complexity. Diabetes Spectrum 3:45-48, 1990. 
32. Heart rate variability: a noninvasive electrocardiographic method to 
measure the autonomic     nervous system.  EWING D J,CAMPBELL 
IW,CLARKE BF. THE NATURAL HISTORY OF DIABETIC 
AUTONOMIC NEUROPATHY Q J MED 1980;49(WINTER);95108 
 
 
33. Cardiovascular autonomic nervous system dysfunction inpatients with         
rheumatoid arthritis and systemic lupuserythematosus W. 
LOUTHRENOO, P. RUTTANAUMPAWAN, A. ARAMRATTANA1        
and W. SUKITAWUT  From the Division of Rheumatology, Department 
of Medicine, and  Department of Family  Medicine, Faculty of Medicine, 
Chiang Mai University, Chiang Mai  
34. Attenuated cardiovascular reflexes in rheumatoid arthritis  V. Sandhu, 
S.C. AllenThe Royal Bournemouth Hospital, Dorset 
35. Sandhu, V. and Allen, S. (2004), The effects of age, seropositivity and    
disease duration on autonomic cardiovascular reflexes in patients with         
rheumatoid arthritis. International Journal of Clinical Practice, 58: 740–745. 
doi: 10.1111/j.1368-5031.2004.00210.x 
36. Cardiac autonomic profile in rheumatoid arthritis and systemic lupus   
erythematosus  Lupus (2010) 19, 255—261. Carşamba Government 
Hospital, Carşamba, Samsun, Turkey 
37. Indian J Physiol Pharmacol. 2010 Jan-Mar;54(1):73-9. Autonomic 
(sympathetic) nervous system involvement in rheumatoid arthiritis 
patients. Department of Physiology, Topiwala National Medical College 
and BYL Nair Charitable Hospital, Mumbai 400 008. 
38. Toussirot E, Serratrice G, Valentin P.Autonomic nervous system               
involvement in rheumatoid arthritis. 50 cases.J Rheumatol. 1993 
Sep;20(9):1508-14 
39. Tan J, Akin S, Beyazova M, Sepici V, Tan E. Sympathetic.  skin response 
and R-R interval variation in rheumatoid arthritis. Twosimple tests for the 
assessment of autonomic function. Am J Phys Med .Rehabil 1993; 
72:196–203 
40. Edmonds ME, Jones TC, Saunders WA, Sturrock RD.       
       Autonomicneuropathy in rheumatoid arthritis. Br Med J responses in   
      some of the tests, in particular cold 1979; 2:173–5. 
41. Watkins PJ. Diabetic diarrhea, gastroparesis, and gustatory sweating. In:    
       Dyck PJ, Thomas PK, Asbury AK, et al, eds. Diabetic     
      Neuropathy. Philadelphia: WB Saunders Co; 1987:199-200. 
42.     Bharucha AE, Camilleri M, Low PA, Zinsmeister AR. Autonomic  
         dysfunction in gastrointestinal motility  disorders.  Gut.  Mar  1993;34 (3)           
       : 397 -401. [Medline] 
42. Emedicine/neurology/autonomic neuropathy 
 
 
 
 
 
 
 
 
  
